SCHEMBL21980705

SCHEMBL21980705

CCCCCCCC/C=C\CCCCCCCC(=O)C(C)(CN(C)C)C(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.59
▸ CES1 P23141 2/20 0.59
▸ TERT O14746 3/20 0.53
▸ PTPN1 P18031 3/20 0.53
▸ PPARG P37231 3/20 0.53
▸ PPARD Q03181 3/20 0.53
▸ PPARA Q07869 3/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ BLM P54132 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ FABP4 P15090 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ GMNN O75496 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724408 0.90 FAAH (0.52) FAAHCES1PTPN1PPARGPPARD
SCHEMBL4755679 0.90 FAAH (0.52) FAAHCES1PTPN1PPARGPPARD
SCHEMBL7870486 0.90 FAAH (0.52) FAAHCES1PTPN1PPARGPPARD
SCHEMBL4790143 0.90 FAAH (0.52) FAAHCES1PTPN1PPARGPPARD
Trimethylammonium SCHEMBL25400813 0.85 FAAH (0.65) FAAHCES1TERTPTPN1PPARG
SCHEMBL28348497 0.81 FAAH (0.52) FAAHCES1TERTPTPN1PPARG
SCHEMBL532713 0.81 FAAH (0.63) FAAHCES1TERTPTPN1PPARG
SCHEMBL532715 0.81 FAAH (0.63) FAAHCES1TERTPTPN1PPARG
SCHEMBL22525273 0.80 FAAH (0.71) FAAHCES1TERTPTPN1PPARG
SCHEMBL22525183 0.80 FAAH (0.71) FAAHCES1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105267990-A Pharmaceutical composition containing miRNA-873 and application thereof UNIV QINGDAO 2016-01-27 — — CN claimed
CN-118043068-A RNA vaccine 阿克丘勒斯治疗公司 2024-05-14 — — CN disclosed
CN-114828836-A Lipid and lipid nanoparticle formulations for drug delivery 宾夕法尼亚大学理事会 2022-07-29 — — CN disclosed
CN-114729353-A Expression of engineered tumor-selective proteins 科纳勒生物公司 2022-07-08 — — CN disclosed
CN-107827762-B (2, 3-dioleoyl-propyl) trimethyl ammonium chloride and preparation method and application thereof 苏州东南药业股份有限公司 2020-10-02 — — CN disclosed
US-20200163880-A1 CATIONIC LIPOSOMES DANMARKS TEKNISKE UNIVERSITET (DK) 2020-05-28 — — US disclosed
CN-110507614-A MiR#4 liposome medicament and preparation method thereof CHENGDU HONGJI XINRUI BIO TECH CO LTD 2019-11-29 — — CN disclosed
CN-105267990-B A kind of medical composition and its use containing miRNA-873 青岛大学 2019-05-10 — — CN disclosed
CN-105267990-A Pharmaceutical composition containing miRNA-873 and application thereof UNIV QINGDAO 2016-01-27 — — CN disclosed
CN-104519915-A Pulmonary delivery of mRNA to non-lung target cells SHIRE HUMAN GENETIC THERAPIES 2015-04-15 — — CN disclosed
CN-102676517-A Survivin gene folate receptor targeted novel liposome CAPITAL INST OF PEDIATRICS 2012-09-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200163880-A1 CATIONIC LIPOSOMES CD14, LIPA, CETP FAAH 3560/4885CES1 1206/4885TERT 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback